EXELIXIS INC (EXEL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for EXEL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EXEL | Independent Director | 71 | ["Distinguished Professor of Biology and Oncological Sciences at the University of Utah","Chief Executive Officer of the Huntsman Cancer Institute from 2006 to 2025","Board member of Huntsman Corporation since 2011","Board member of Johnson & Johnson since 2015","Member of various scientific and advisory boards","NACD Corporate Governance Fellow","NACD Directorship 100 Honoree","Elected member of the National Academy of Sciences","Elected member of the American Philosophical Society","Elected member of the American Academy of Arts and Sciences","B.A. in Biology and Psychology (magna cum laude) from Wells College","Ph.D. in Molecular, Cellular and Developmental Biology from the University of Colorado, Boulder","Post-doctoral fellowship in Anatomy and Cell Biology at the University of North Carolina at Chapel Hill"] | ["Governance Committee","Research & Development Committee","Risk Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JNJ | Independent Director | 71 | ["Distinguished Professor of Biology and Oncological Sciences at University of Utah","Chief Executive Officer Emerita at Huntsman Cancer Institute","Expertise in scientific research and organizational management in the healthcare arena","Active participant in national and international scientific affairs","Strong focus on patient experience"] | ["Chair, Science & Technology","Member, Regulatory Compliance & Sustainability"] | 2026 |
Biography sourced from the proxy statement filing.
Mary C. Beckerle, Ph.D., has been a director since January 2024. She currently serves as a Distinguished Professor of Biology and Oncological Sciences at the University of Utah. She first joined the faculty of the University of Utah in 1986, where she has held numerous research and leadership roles, and served as Chief Executive Officer of the Huntsman Cancer Institute from 2006 to 2025. Dr. Beckerle has served as a member of the board of directors of: Huntsman Corporation, a publicly held global manufacturer of specialty chemicals, since 2011; Johnson & Johnson, a publicly held diversified healthcare company, since 2015; and Halia Therapeutics, a privately held biopharmaceutical company, since 2026. She has been named a National Association of Corporate Directors (NACD) Corporate Governance Fellow and was a 2018 NACD Directorship 100 Honoree. Dr. Beckerle currently serves on several scientific and advisory boards, including the Medical Advisory Board of the Howard Hughes Medical Institute since 2015, as well as an external advisory board of a National Cancer Institute-designated cancer center at the University of Pennsylvania. Previously, Dr. Beckerle served as a member of the Board of Scientific Advisors of the National Cancer Institute from 2018 to 2022, the External Advisory Board of the Dana-Farber/Harvard Cancer Center from 2013 to 2022, the Board of Directors of the American Association for Cancer Research from 2013 to 2016, the American Cancer Society Council for Extramural Grants from 2008 to 2012 (serving as Chair from 2010 to 2012) and the National Institutes of Health's Advisory Committee to the Director from 2007 to 2010, and from 2024 to 2025, as well as President of the American Society for Cell Biology from 2006 to 2007. She is also an elected member of the National Academy of Sciences, the American Philosophical Society and the American Academy of Arts and Sciences. Dr. Beckerle holds a B.A. in Biology and Psychology (magna cum laude) from Wells College, a Ph.D. in Molecular, Cellular and Developmental Biology from the University of Colorado, Boulder and completed her post-doctoral fellowship in Anatomy and Cell Biology at the University of North Carolina at Chapel Hill.